Skip to content

Comparing the Oxytocin made in Iran with Oxytocin from foreign country for induction of labor

A comparative study of the use of oxytocin (Iranian-made and foreign) in the induction of labor.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201011275181N3
Enrollment
100
Registered
2012-01-12
Start date
2011-04-09
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long labor. Long labour

Interventions

Intervention 1: The group 1 (oxytocin), First 10 units oxytocin spilled in 1000 cc of blood Ringer (2/5mu/min) Then four drops per minute infusion rate 2 / 5 is increased to the maximum mu / min 40 in
Treatment - Drugs
The group 1 (oxytocin), First 10 units oxytocin spilled in 1000 cc of blood Ringer (2/5mu/min) Then four drops per minute infusion rate 2 / 5 is increased to the maximum mu / min 40 in. The same amou
The group 2 (oxytocip), First 10 units oxytocin spilled in 1000 cc of blood Ringer (2/5mu/min) Then four drops per minute infusion rate 2 / 5 is increased to the maximum mu / min 40 in. The same amou

Sponsors

Caspian Pharmaceutical Company
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: one Fetal pregnancy; Cephalic presentation; intact amniotic membrane; Reactive NST; less than 3 uterus contraction per 10 minutes. Exclusion criteria: regular contraction (more than 6 contraction per hours); fetal death; Amniotomy contra indication; mother age less than 18 years; previous C/S; Multiparty (>3); Chorioamniotit; Asthma history; Multiple gestation; Placenta previa; Non Cephalic presentation; Glucoma; Vaginal bleeding; sensitivity to Prostoglandin; irregular in fetal heart rate; contra indication of vaginal delivery.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Cesarian Section. Timepoint: at the end of induction of labor. Method of measurement: C/S or vaginal delivery.

Secondary

MeasureTime frame
Duration of labor induction. Timepoint: Since the beginning of induction to delivery time. Method of measurement: Based on time.;Duration of first labor period. Timepoint: begining of induction until delivery time. Method of measurement: based on hours.;During the second stage of labor. Timepoint: Onset of contractions to full cervical dilatation. Method of measurement: Based on time.;Uterine hyper stimulation. Timepoint: Time of contraction is more than two minutes. Method of measurement: Based on an specialist examination.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026